DE69228952D1 - Verwendung von psoralen-verbindungen zur hemmung von auf gefaessplastiken folgende restenosen - Google Patents

Verwendung von psoralen-verbindungen zur hemmung von auf gefaessplastiken folgende restenosen

Info

Publication number
DE69228952D1
DE69228952D1 DE69228952T DE69228952T DE69228952D1 DE 69228952 D1 DE69228952 D1 DE 69228952D1 DE 69228952 T DE69228952 T DE 69228952T DE 69228952 T DE69228952 T DE 69228952T DE 69228952 D1 DE69228952 D1 DE 69228952D1
Authority
DE
Germany
Prior art keywords
photopheresis
patient
blood
affected tissue
plastics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228952T
Other languages
English (en)
Other versions
DE69228952T2 (de
Inventor
Emil Bisaccia
Albert S Klainer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69228952D1 publication Critical patent/DE69228952D1/de
Application granted granted Critical
Publication of DE69228952T2 publication Critical patent/DE69228952T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
DE69228952T 1991-12-17 1992-12-17 Verwendung von psoralen-verbindungen zur hemmung von auf gefaessplastiken folgende restenosen Expired - Fee Related DE69228952T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/809,590 US5284869A (en) 1991-12-17 1991-12-17 Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty
PCT/US1992/010982 WO1993011657A2 (en) 1991-12-17 1992-12-17 The use of psoralen compounds to inhibit restenosis following angioplasty

Publications (2)

Publication Number Publication Date
DE69228952D1 true DE69228952D1 (de) 1999-05-20
DE69228952T2 DE69228952T2 (de) 1999-10-21

Family

ID=25201702

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228952T Expired - Fee Related DE69228952T2 (de) 1991-12-17 1992-12-17 Verwendung von psoralen-verbindungen zur hemmung von auf gefaessplastiken folgende restenosen

Country Status (9)

Country Link
US (2) US5284869A (de)
EP (1) EP0661920B1 (de)
AT (1) ATE178757T1 (de)
AU (2) AU3328393A (de)
DE (1) DE69228952T2 (de)
DK (1) DK0661920T3 (de)
ES (1) ES2131572T3 (de)
GR (1) GR3032388T3 (de)
WO (1) WO1993011657A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284869A (en) * 1991-12-17 1994-02-08 Emil Bisaccia Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty
US5116864A (en) * 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6663881B2 (en) * 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
US6008211A (en) * 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
US5902299A (en) * 1997-07-29 1999-05-11 Jayaraman; Swaminathan Cryotherapy method for reducing tissue injury after balloon angioplasty or stent implantation
WO2000041726A2 (en) * 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
US7125897B1 (en) * 1999-09-24 2006-10-24 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US8109981B2 (en) * 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
WO2007106856A2 (en) * 2006-03-14 2007-09-20 Allux Medical, Inc. Phototherapy device and method of providing phototherapy to a body surface
US20070219600A1 (en) * 2006-03-17 2007-09-20 Michael Gertner Devices and methods for targeted nasal phototherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US5284869A (en) * 1991-12-17 1994-02-08 Emil Bisaccia Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty
US5116864A (en) * 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels

Also Published As

Publication number Publication date
GR3032388T3 (en) 2000-05-31
AU3328393A (en) 1993-07-19
US5426116A (en) 1995-06-20
DK0661920T3 (da) 1999-10-25
DE69228952T2 (de) 1999-10-21
AU3688497A (en) 1997-12-18
ATE178757T1 (de) 1999-04-15
EP0661920A1 (de) 1995-07-12
ES2131572T3 (es) 1999-08-01
US5284869A (en) 1994-02-08
WO1993011657A2 (en) 1993-06-24
EP0661920A4 (de) 1995-03-02
EP0661920B1 (de) 1999-04-14

Similar Documents

Publication Publication Date Title
DE69228952D1 (de) Verwendung von psoralen-verbindungen zur hemmung von auf gefaessplastiken folgende restenosen
DE69230285D1 (de) Methode zur verhinderung von restenosierung nach rekanalisierung von körpergefässen
US5514707A (en) Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light
DE69201948D1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
ES2121592T3 (es) Inhibicion de la reestenosis por radiacion ultravioleta.
DE69012591D1 (de) Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
ATE129156T1 (de) Verwendung von sulfatierten oligosacchariden zur behandlung arteriosklerotischer erkrankungen und zur verhinderung der restenosierung.
DE59307982D1 (de) Verwendung von NADH und NADPH zur Herstellung eines Arzneimittels zur Behandlung von Morbus Alzheimer
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
ATE24911T1 (de) Pyrido(3',4':4,5)furo(3,2-g)coumarine oder pyrido(3,4-h)psoralene, herstellung, verwendung in der kosmetologie und als arzneimittel und diese enthaltende zubereitungen.
ATE220065T1 (de) Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten
CA2117330C (en) The use of psoralen compounds to inhibit restenosis following angioplasty
AU753208B2 (en) The use of psoralen compounds to inhibit restenosis following angioplasty
ATE235252T1 (de) Methode zur verminderung arterieller stenose
DE69411833D1 (de) Verwendung von Chinonen zur Herstellung eines Arzneimittels zur Vorbeugung und Behandlung von allergischer Rhinitis
Debta et al. Photochemotherapy (PUVA): an overview
Sterk et al. The lens and PUVA therapy
UA10221A (uk) Спосіб лікування рецидивного бронхіту у дітей
Yang et al. Treating esophagus-cardiac carcinoma by YAG laser gasifying with irradiating of hemoporphyrin derivative laser: additional analyses of 110 cases
Jurkowitsch et al. Light Treatment in Medicine
MX9702985A (es) Endoprotesis temporal de flujo pasante emisora de radiacion.
GR3015570T3 (en) Imidazolylpropylguanidine-derivative, process for its preparation and medicaments containing it.
NO951966L (de)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee